On Sunday 14 June, Diabetes.co.uk will be conducting a live Q&A with Dr. Partha Kar, Clinical Director of Diabetes at Portsmouth Hospitals NHS Trust.

Dr. Kar has been a Consultant in Diabetes & Endocrinology since 2008; he took up the role of Clinical Director of Diabetes in 2009, and has held the position since. Dr. Kar’s interests lie in the design of diabetes care. The super six model – which he pioneered – won the Care Integration Awards 2012 and the Quality in Care in Diabetes Award 2012.

It is no coincidence that Dr. Kar’s Q&A precedes diabetes week, the theme of which is patient care and support. On Sunday 14 June, Dr. Kar will be fielding questions from Diabetes.co.uk users on this topic.

Dr. Kar will be answering questions between 7pm and 8pm (1900-2000) on 14 June. If you have a question about the current state of diabetes care in the country, or a problem with your own personal diabetes care, or a query about the future of diabetes care in the UK – get in touch.

Dr. Kar’s other innovations include the Hypoglycemia Hotline – which was noted at the Guardian Healthcare Awards 2013 – and the Type 1 Diabetes service, which utilises technology and social media to improve the health and care of young people with type 1 diabetes.

Dr. Kar also holds the role of Clinical Service Director for community services in South East Hampshire, along with being nominated to the General Advisory Council of the Kings Fund. He has recently joined Ascot & Bracknell CCG as a secondary care advisor along with being appointed as a Specialist advisor for the Care Quality Commission.

Questions can be posted in advance on the Diabetes.co.uk forum thread, or asked during the Q&A itself on Facebook or Twitter.
Diabetes.co.uk has been conducting monthly Q&A sessions throughout 2015, giving users the chance to ask diabetes-related questions to experts such as doctors, nutritionists and, and dietitians. In May, Diabetes.co.uk conducted an interview with Dr. David Cavan, in which he answered questions about diet and diabetes management for people with type 2 diabetes.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.